San Diego, California-based Cue, not to be confused with fertility tracker company Clue, raised $7.5 million in a round led by SherpaVentures with participation from existing investor Immortalana.
The global diagnostics market was valued at approximately $180 billion in 2022 and is projected to grow to over $348 billion by 2030. Some of the key drivers of that growth are molecular diagnostics ...